KAT5 and cancer: Exploring the clinical significance of HSP90A and TIP60 in TNBC using the PROGgeneV2 Pan-Cancer Prognostic Database (http://www.progtools.net/gene/), we found that TNBC patients with joint high expression of HSP90A and TIP60 exhibit shorter survival times (Fig. S18).